Company profile: Alpex
1.1 - Company Overview
Company description
- Provider of research and development and production of orally dispersible tablets (ODT), also known as fast melt, and effervescent tablets. Offers a unique proprietary covering ODT technology, supported by high production capacity and advanced R&D technologies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alpex
Cognivia
HQ: Belgium
Website
- Description: Provider of analytical tools and services to optimize and speed clinical development of novel medicines, including Placebell to reduce data variability by addressing placebo response and patient heterogeneity; Compl-AI to predict non-adherence and dropout risks to aid patient engagement; and an Expert Analysis Service to detect and explain clinical site variability and help adjust data for clearer study results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cognivia company profile →
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
Perigord
HQ: Ireland
Website
- Description: Provider of best-in-class labeling artwork to life science companies, with unparalleled expertise in highly regulated sectors, and developer of the world’s only dedicated Pharmaceutical Artwork Management System, GLAMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perigord company profile →
XenoGesis
HQ: United Kingdom
Website
- Description: Provider of preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis, and expert interpretation as a specialised CRO.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XenoGesis company profile →
Exela Pharma Sciences
HQ: United States
Website
- Description: Provider of sterile injectable pharmaceuticals for the healthcare sector, offering Sodium Bicarbonate Injection (electrolyte replenisher/systemic alkalizer), Caffeine Citrate Injection, ELCYS (cysteine hydrochloride injection), GLYRX-PF (synthetic anticholinergic), Nipride RTU (sodium nitroprusside), and Caffeine Citrate Oral Solution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exela Pharma Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alpex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alpex
2.2 - Growth funds investing in similar companies to Alpex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alpex
4.2 - Public trading comparable groups for Alpex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →